Maria Trinidad Herrero Ezquerro

Pavon-Pulido N, Blasco-Garcia JD, Lopez-Riquelme JA, Feliu-Batlle J, Oterino-Bono R, Herrero MT. JUNO Project: Deployment and Validation of a Low-Cost Cloud-Based Robotic Platform for Reliable Smart Navigation and Natural Interaction with Humans in an Elderly Institution. Sensors (Basel). 2023 Jan 2;23(1):483. doi: 10.3390/s23010483. PubMed PMID: 36617079; PubMed Central PMCID: PMC9824260.

AÑO: 2023; IF: 3.847

36617079

Mandala C, Veronese N, Dominguez LJ, Candore G, Accardi G, Smith L, Herrero MT, Barbagallo M. Use of bioelectrical impedance analysis in centenarians: a systematic review. Aging Clin Exp Res. 2023 Jan;35(1):1-7. doi: 10.1007/s40520-022-02282-x. Epub 2022 Oct 26. PubMed PMID: 36287324; PubMed Central PMCID: PMC9816227.

AÑO: 2023; IF: 4.0

36287324

Herrero MT, Yuste JE, Cuenca-Bermejo L, Almela P, Arenas-Betancur L, De Pablos V, Gonzalez-Cuello A, Del Bel E, Navarro-Zaragoza J, Fernandez-Villalba E. 7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate. Open Biol. 2023 May;13(5):220370. doi: 10.1098/rsob.220370. Epub 2023 May 17. PubMed PMID: 37192671; PubMed Central PMCID: PMC10188238.

AÑO: 2023; IF: 7.124

37192671

De Araujo FM, Frota AF, de Jesus LB, Macedo TC, Cuenca-Bermejo L, Sanchez-Rodrigo C, Ferreira KMS, de Oliveira JVR, de Fatima Dias Costa M, Segura-Aguilar J, Costa SL, Herrero MT, Silva VDA. Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson's Disease. Cell Mol Neurobiol. 2023 Jan;43(1):265-281. doi: 10.1007/s10571-021-01173-5. Epub 2022 Jan 6. PubMed PMID: 34988761.

AÑO: 2023; IF: 4.0

34988761

Romo-Vaquero M, Fernandez-Villalba E, Gil-Martinez AL, Cuenca-Bermejo L, Espin JC, Herrero MT, Selma MV. Urolithins: potential biomarkers of gut dysbiosis and disease stage in Parkinson's patients. Food Funct. 2022 Jun 6;13(11):6306-6316. doi: 10.1039/d2fo00552b. PubMed PMID: 35611932.

AÑO: 2022; IF: 6.1

35611932